{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T13:59:03Z","timestamp":1781877543590,"version":"3.54.5"},"reference-count":19,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2003,1,16]],"date-time":"2003-01-16T00:00:00Z","timestamp":1042675200000},"content-version":"vor","delay-in-days":15,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2003,1]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background<\/jats:bold> :\u2002Endoscopic therapies and continuous intravenous omeprazole can decrease the morbidity and duration of hospital stay of patients with high\u2010risk peptic ulcer.<\/jats:p><jats:p><jats:bold>Aim<\/jats:bold> :\u2002To evaluate the role of oral omeprazole in high\u2010risk bleeders.<\/jats:p><jats:p><jats:bold>Methods<\/jats:bold> :\u2002After injection therapy of 160 patients with high\u2010risk peptic ulcer, 80 received oral omeprazole and 80 received placebo, and all were followed up.<\/jats:p><jats:p><jats:bold>Results<\/jats:bold> :\u2002One hundred and forty\u2010nine patients (71 omeprazole and 78 placebo) completed the study. Eleven patients were excluded from the study. Thirty\u2010seven (25%) patients had gastric ulcer and 112 (75%) had duodenal ulcer. Fifty\u2010seven (38%) ulcers showed visible vessels, 80 (54%) showed oozing of blood and 12 (8%) showed a spurting artery. Only one patient died (placebo group). The mean hospital stays were 62.8\u2003\u00b1\u200328.6\u2003h and 75\u2003\u00b1\u200339\u2003h in the omeprazole and placebo groups, respectively (<jats:italic>P<\/jats:italic>\u2003=\u20030.032). The mean amounts of blood transfused were 1.13\u2003\u00b1\u20031.36 and 1.68\u2003\u00b1\u20031.68 bags in the omeprazole and placebo groups, respectively (<jats:italic>P<\/jats:italic>\u2003=\u20030.029). The re\u2010bleeding rate was lower in the omeprazole group than in the placebo group (12 vs. 26, respectively; <jats:italic>P<\/jats:italic>\u2003=\u20030.022).<\/jats:p><jats:p><jats:bold>Conclusion<\/jats:bold> :\u2002Oral omeprazole is effective in decreasing the hospital stay, re\u2010bleeding rate and the need for blood transfusion in high\u2010risk ulcer bleeders treated with endoscopic injection therapy.<\/jats:p>","DOI":"10.1046\/j.1365-2036.2003.01416.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:48:48Z","timestamp":1047354528000},"page":"211-216","source":"Crossref","is-referenced-by-count":89,"title":["Effect of oral omeprazole in reducing re\u2010bleeding in bleeding peptic ulcers: a prospective, double\u2010blind, randomized, clinical trial"],"prefix":"10.1111","volume":"17","author":[{"given":"M. J.","family":"Kaviani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. R.","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. R.","family":"Kazemifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Roozitalab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.\u2010A.","family":"Mostaghni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Merat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Alizadeh\u2010Naini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Yarmohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,1,16]]},"reference":[{"key":"e_1_2_13_2_2","first-page":"206","article-title":"Epidemiology of hospitalization for acute upper gastrointestinal hemorrhage: a population\u2010based study","volume":"90","author":"Longstreth GF","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_13_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-198801000-00002"},{"key":"e_1_2_13_4_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-34-2-339"},{"key":"e_1_2_13_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199409153311107"},{"key":"e_1_2_13_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199704103361503"},{"key":"e_1_2_13_7_2","first-page":"S42","article-title":"Heat probe for hemostasis of bleeding peptic ulcers: techniques and results of randomized controlled trials","volume":"36","author":"Jensen DM","year":"1990","journal-title":"Gastrointest Endosc"},{"key":"e_1_2_13_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(87)91191-3"},{"key":"e_1_2_13_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(92)91793-4"},{"key":"e_1_2_13_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6109(05)70424-2"},{"key":"e_1_2_13_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00623.x"},{"key":"e_1_2_13_12_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529709007691"},{"key":"e_1_2_13_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.27.3.243"},{"key":"e_1_2_13_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(78)90352-9"},{"issue":"1","key":"e_1_2_13_15_2","first-page":"47","article-title":"Tolerance during 8 days of high\u2010dose H2\u2010blockade: placebo\u2010controlled studies of 24\u2010hour acidity and gastrin","volume":"4","author":"Smith JTL","year":"1990","journal-title":"Aliment Pharmacol Ther"},{"key":"e_1_2_13_16_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529709007679"},{"key":"e_1_2_13_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(01)00812-9"},{"key":"e_1_2_13_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200008033430501"},{"key":"e_1_2_13_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.2000.02055.x"},{"key":"e_1_2_13_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.21.4.324"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2003.01416.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2003.01416.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.2003.01416.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T00:14:44Z","timestamp":1697242484000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.2003.01416.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["10.1046\/j.1365-2036.2003.01416.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.2003.01416.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,1]]}}}